Bristlecone Advisors, LLC Gilead Sciences, Inc. Transaction History

Bristlecone Advisors, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 25, 2021	SELL	$56.65 - $64.55 $970,074 - $1.11 Million	-17,124 Closed	0 $0
Q3 2020 Oct 20, 2020	SELL	$62.1 - $78.08 $434,824 - $546,716	-7,002 Reduced 29.02%	17,124 $1.08 Million
Q2 2020 Jul 16, 2020	BUY	$72.34 - $84.0 $1.14 Million - $1.32 Million	15,741 Added 187.73%	24,126 $1.86 Million
Q1 2020 Apr 16, 2020	BUY	$62.63 - $80.22 $4,070 - $5,214	65 Added 0.78%	8,385 $627,000
Q4 2019 Jan 21, 2020	BUY	$61.62 - $67.78 $18,794 - $20,672	305 Added 3.81%	8,320 $541,000
Q3 2019 Oct 28, 2019	SELL	$62.51 - $69.0 $223,723 - $246,951	-3,579 Reduced 30.87%	8,015 $508,000
Q2 2019 Jul 19, 2019	SELL	$61.87 - $69.38 $850,836 - $954,113	-13,752 Reduced 54.26%	11,594 $783,000
Q1 2019 Apr 23, 2019	SELL	$62.53 - $70.05 $41,582 - $46,583	-665 Reduced 2.56%	25,346 $1.65 Million
Q4 2018 Jan 15, 2019	SELL	$60.54 - $79.0 $1,513 - $1,975	-25 Reduced 0.1%	26,011 $1.63 Million
Q3 2018 Oct 22, 2018	BUY	$71.28 - $78.92 $836,898 - $926,599	11,741 Added 82.13%	26,036 $2.01 Million
Q2 2018 Jul 31, 2018	SELL	$64.88 - $75.68 $286,639 - $334,354	-4,418 Reduced 23.61%	14,295 $1.01 Million
Q1 2018 Apr 24, 2018	SELL	$72.84 - $88.8 $490,358 - $597,801	-6,732 Reduced 26.46%	18,713 $1.41 Million
Q4 2017 Jan 30, 2018	SELL	$71.15 - $83.52 $77,197 - $90,619	-1,085 Reduced 4.09%	25,445 $1.82 Million
Q3 2017 Oct 20, 2017	BUY	$72.11 - $85.47 $1.91 Million - $2.27 Million	26,530	26,530 $2.15 Million

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Bristlecone Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Bristlecone Advisors, LLC with notifications on news.